South Korea’s Boryung Pharmaceutical announced on Aug. 27 it had received approval from the US Food and Drug Administration to start a phase 1 clinical trial of its drug candidate BR2002 The phase 1 clinical trial will be conducted among 90 patients who suffer...
United Health Products, Inc. (UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 October 15, 2013), for the healthcare and wound care sectors, today...
Cancer and neurological condition focused Evgen Pharma said the last study visit had been conducted for the final patient entered into a recent clinical trial of a treatment for subarachnoid haemorrhage, a type of stroke. In the placebo-controlled SAS phase II...
Boasting over one billion monthly active users, as well as more than 50 billion photos shared, Instagram is one of the most engaging social media platforms. Not only is it a popular platform among young adults aged 18-24, but businesses have taken advantage of its...
– DelMar Pharmaceuticals, Inc. (DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of novel cancer therapies, today announced that the Company anticipates that its current cash position, which...
New draft guidance features recommendations on the development and labeling of cancer drugs for men with breast cancer August 26, 2019 — The U.S. Food and Drug Administration (FDA) released a new draft guidance that encourages including male patients in breast...
Email
Text